BLADE Entertainment CO.,LTD.

Equities

A044480

KR7044480002

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
983 KRW +3.58% Intraday chart for BLADE Entertainment CO.,LTD. +0.82% -13.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in funding CI
Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4% MT
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in funding CI
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 10 billion in funding CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6 billion in funding CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6 billion in funding CI
Blueberry NFT CO.,LTD. announced that it has received KRW 5 billion in funding from Metaplex Co., Ltd. CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 5 billion in funding from Metaplex Co., Ltd. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6.999999435 billion in funding from Jang San Co.,Ltd. CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6.999999435 billion in funding from Jang San Co.,Ltd. CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd. CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 9.999999625 billion in funding from Jangsan Co., Ltd. CI
Kyung Nam Biopharma CO.,LTD. announced that it expects to receive KRW 9.999999625 billion in funding from Jangsan Co., Ltd. CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD. CI
Livefinancial Co.,Ltd. acquired additional 5.8% stake in KyungNam Biopharma CO.,LTD. from Widwin Investment Co., Ltd. for KRW 4 billion. CI
ESV Inc. announced that it has received KRW 4.999999932 billion in funding from KyungNam Biopharma CO.,LTD. CI
KyungNam Biopharma CO.,LTD. announced that it has received KRW 1.499998005 billion in funding from Livefinancial Co.,Ltd. CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD. CI
BioGenetics CO.,LTD. announced that it expects to receive KRW 1.499998005 billion in funding from Livefinancial Co.,Ltd. CI
CODI-M Co., LTD. announced that it has received KRW 1.999999944 billion in funding from BioGenetics CO.,LTD. CI
ESV Inc. announced that it expects to receive KRW 4.999999932 billion in funding CI
BioGenetics CO.,LTD. announced that it has received KRW 20 billion in funding from Widwin Investment Co., Ltd. CI
BioGenetics CO.,LTD. announced that it expects to receive KRW 20 billion funding from Widwin Investment Co., Ltd. and other investors CI
Chart BLADE Entertainment CO.,LTD.
More charts
Blade Entertainment Co Ltd, formerly Blueberry NFT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the manufacture and sale of medicines such as vitamins, placentas and health foods. The Company is also engaged in the manufacture and sale of rubber products such as condoms and gloves, as well as masks such as KF-94. In addition, the Company is engaged in the development and provision of software such as non-fungible tokens (NFTs).
More about the company
  1. Stock Market
  2. Equities
  3. A044480 Stock
  4. News BLADE Entertainment CO.,LTD.
  5. Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4%